Compare CPRX & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPRX | EQX |
|---|---|---|
| Founded | 2002 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 10.9B |
| IPO Year | 2006 | N/A |
| Metric | CPRX | EQX |
|---|---|---|
| Price | $23.72 | $14.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $32.60 | $17.00 |
| AVG Volume (30 Days) | 1.2M | ★ 7.5M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.94 | N/A |
| EPS | ★ 1.71 | 0.11 |
| Revenue | $578,196,000.00 | ★ $2,296,356,000.00 |
| Revenue This Year | $19.87 | $78.78 |
| Revenue Next Year | $7.21 | $60.10 |
| P/E Ratio | ★ $13.83 | $129.07 |
| Revenue Growth | 25.56 | ★ 85.65 |
| 52 Week Low | $19.05 | $4.95 |
| 52 Week High | $26.58 | $15.10 |
| Indicator | CPRX | EQX |
|---|---|---|
| Relative Strength Index (RSI) | 62.17 | 68.32 |
| Support Level | $22.20 | $13.37 |
| Resistance Level | $23.84 | $14.36 |
| Average True Range (ATR) | 0.60 | 0.60 |
| MACD | -0.06 | 0.07 |
| Stochastic Oscillator | 91.01 | 86.79 |
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.